Company attributes
Venture Capital Firm attributes
Other attributes
RiverVest Venture Partners focuses exclusively on innovations in life sciences, a field in which their team has significant research, clinical, operational and investment expertise. The team's deep domain experience allows them to identify promising investment opportunities, particularly in biopharmaceuticals and medical devices. They provide practical advice and strategic leadership to help entrepreneurs drive early-stage companies forward. RiverVest founds and actively incubates life science companies, including through its Archer Seed Fund. The Firm also invests in select later-stage opportunities to diversify risk and maximize portfolio returns. In every case, it takes a hands-on investment approach, preferring to be represented on the boards of their portfolio companies.
RiverVest Venture Partners' investments include Excaliard Pharmaceuticals, Cabrellis Pharmaceuticals, MacroGenics, Kereos, Velocimed, Auxeris Therapeutics, Salient Surgical Technologies and NexRay.
Their exited investments include Allakos, Mirum Pharmaceuticals, ZS Pharma, Otonomy, MacroGenics, Accumetrics, Lumena Pharmaceuticals, IDEV Technologies, Securus Medical Group and Lutonix.
